LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 91.27 | 84.90 | 218 | 7420 | 0.0294 | 0.1575 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 91.27 | 84.90 | 2471 | 7420 | 0.3330 | 0.6865 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 92.98 | 84.90 | 3333 | 7257 | 0.4592 | 0.7716 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 92.98 | 84.90 | 3386 | 7257 | 0.4665 | 0.7760 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 92.98 | 84.90 | 214 | 7257 | 0.0295 | 0.1550 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 92.98 | 84.90 | 2508 | 7257 | 0.3456 | 0.6948 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 94.68 | 84.90 | 3429 | 7000 | 0.4898 | 0.7879 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 94.68 | 84.90 | 3490 | 7000 | 0.4985 | 0.7928 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 94.68 | 84.90 | 193 | 7000 | 0.0276 | 0.1377 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 94.68 | 84.90 | 2544 | 7000 | 0.3634 | 0.7060 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 2.66 | 84.90 | 544 | 285 | 1.9038 | 1.8889 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 2.66 | 84.90 | 673 | 285 | 2.3553 | 2.2623 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 4.36 | 84.90 | 2 | 322 | 0.0062 | -0.8572 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 4.36 | 84.90 | 623 | 322 | 1.9314 | 1.8149 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 4.36 | 84.90 | 752 | 322 | 2.3313 | 2.1039 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 6.06 | 84.90 | 679 | 365 | 1.8580 | 1.6840 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 6.06 | 84.90 | 841 | 365 | 2.3013 | 1.9711 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.77 | 84.90 | 4 | 411 | 0.0097 | -0.7387 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.77 | 84.90 | 741 | 411 | 1.8019 | 1.5905 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | I05 |